
James Lumsdaine
Interim Chief Executive Officer
In February of 2022 Imagia Cybernetics, an AI-healthcare company that accelerates oncology solutions generated from real-world data, and Canexia Health, an oncology innovator that streamlines complex cancer genomic information for use in treatment selection and patient monitoring, came together to form Imagia Canexia Health. Together, Imagia Canexia Health accelerates access to precision oncology leading to optimized treatment selection and better patient outcomes. Our expertise in genomics-based cancer assays, bioinformatics, and machine learning runs deep thanks to the strong foundation laid by our combined scientific, medical, and business leader
Interim Chief Executive Officer
Chief Financial Officer
Chief Medical Officer
Chief Science Officer
Chief Business Officer
Executive Vice President Corporate & Public Affairs
Vice President, Oncology & Clinical Strategy
March 28, 2023
Imagia Canexia Health announced that three abstracts highlighting the company’s new learnings and tools will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2023, taking place April 14-19, 2023, at the Orange County Convention Center in Orlando, Florida.
December 1, 2022
The holiday season is around the corner and we would like to inform everyone of our operation schedule over Christmas and New Year.
September 22, 2022
Appointment fortifies Imagia Canexia Health’s board with leading expertise in successfully scaling biopharma and diagnostics enterprises
June 15, 2022
Imagia Canexia Health, a genomics-based cancer treatment testing company that accelerates access to precision care by combining AI expertise with advanced molecular biopsy solutions, today announced the CE-IVD marking for its Imagia Canexia Health Insights Platform (ICHIP) to operate across Europe.
April 21, 2022
Vancouver, BC [April 21, 2022] – Canada’s Digital Technology Supercluster is excited to be
February 17, 2022
Merger includes C$20 million investment to accelerate access to genomics-based testing for cancer treatment by combining Canexia Health’s advanced molecular cancer solutions with Imagia Cybernetics’ healthcare and AI expertise
Sorry, nothing at the moment.
November 16, 2021 10:30 am
Establishing an In-House Molecular Profiling Program for Cancer Treatment Selection
November 18, 2020
Canexia Health will be participating in the Association for Molecular Pathology (AMP) 2020 Annual Meeting & Expo, which will be held virtually November 16-20, 2020
Imagia Canexia Health puts the latest precision oncology innovations within reach for all cancer care organizations.
Our precision oncology solutions digitize biologic samples and make high-quality genomic information accessible and affordable. Discover our platforms for plasma and tissue profiling.